Health

  • October 19, 2026

    Pot Co. Ascend Says It Had Good Reasons To Fire Executive

    Major cannabis company Ascend Wellness has urged a New York federal judge to find that a wrongful termination case brought by a former executive should be thrown out because the company documented a record of inappropriate behavior and fulfilled its duties to communicate its reasons for firing him.

  • October 19, 2026

    Accused In $91M Health Plan Scam Asks To Halt FTC Suit

    A woman accused of running a $91 million fraudulent health benefits scheme with her brother urged a Florida federal court on Monday to pause the Federal Trade Commission's lawsuit against her if related criminal charges proceed in court. 

  • October 19, 2026

    Mass. Court Affirms Doctor's Partial Win Over Insurer

    A doctor whose career was cut short after losing the use of his feet is entitled to damages from Paul Revere Life Insurance Co. for breach of contract and unfair settlement practices under state law, but cannot revive other claims tossed by a judge or extend the statute of limitations, an intermediate appellate court said Monday.

  • October 19, 2026

    Prior 5th Amendment Pleadings Complicate Mylan Testimony

    Mylan can use deposition testimony from one current and one former executive in next year's price-fixing trial, a Connecticut federal judge ruled Friday, but state attorneys general can bring up the company "pulling the strings" in the witnesses' decision to testify after originally invoking the Fifth Amendment.

  • October 19, 2026

    Biz Groups Back Health System's Win In 401(k) Forfeiture Suit

    The U.S. Chamber of Commerce and an employee benefit administrator trade group backed a Louisiana healthcare system's win over a lawsuit challenging its use of forfeited 401(k) funds to cover employer contributions, telling the Fifth Circuit that federal regulations have greenlighted the practice for decades.

  • October 19, 2026

    DOJ Appeals New Trial Order In Ex-NFL Player's Fraud Case

    The U.S. Department of Justice said it's asking the Fifth Circuit to review a Texas federal judge's decision to grant a new trial for a former NFL player convicted in a $328 million Medicare billing scheme.

  • October 16, 2026

    Conduent Inks $80M Breach Deal With 62M Class Members

    Victims of a data breach at Conduent Business Services LLC on Friday asked a New Jersey federal judge to greenlight an $80 million settlement resolving their claims that the company failed to adequately protect sensitive personal and health information of about 62 million people.

  • October 16, 2026

    2nd Circ. Denies Rehearing In Tylenol Autism Suits

    The Second Circuit on Friday denied a bid by Tylenol maker Kenvue and several retailers to reconsider its ruling that a district court improperly excluded expert testimony for plaintiffs who claim prenatal exposure to the over-the-counter pain reliever causes autism and ADHD.

  • October 16, 2026

    NY, Conn. Secure $2.7M Deal Over Health Network Data Breach

    A pediatric health network and its information technology manager have agreed to pay $2.7 million to resolve the New York and Connecticut attorneys general's claims that they failed to institute "common" security measures to protect the personal data of patients impacted by a 2024 data breach, the states announced Friday. 

  • October 16, 2026

    Suing The Trump Admin Can Have Massive Impact, Attys Say

    Lawyers representing clients against the federal government spoke Friday about the challenges and rewards of such litigation in the Trump era, with plaintiff-side powerhouse Elizabeth Cabraser pointing to the potential for massive impact, including one case in which she successfully got more than a billion dollars in grant funding reinstated.

  • October 16, 2026

    NY Nursing Home Hit With $6.8M Verdict In Understaffing Case

    A New York state jury reached a $6.8 million verdict against a nursing home accused of understaffing its approximately 62-bed facility and causing severe patient neglect, counsel for a certified class of residents at the facility announced Friday.

  • October 16, 2026

    Hospital Operator Challenges NC AG's Power Over Merger

    HCA Healthcare is taking another crack at throwing out the North Carolina attorney general's suit alleging HCA broke its promise to maintain a certain level of care at an Asheville hospital it purchased, saying his office lacks the power to enforce a merger between two private parties.

  • October 16, 2026

    Device Co. Accused Of Shorting Co-Founder's Payments

    The co-founder of a company that sells medical devices told a Colorado state court Thursday that the company lowered the percentage he is owed of $7.7 million in outstanding receivables from a client without approval.

  • October 16, 2026

    FTC Wants More Info On $350M Surgical Supplies Deal

    The Federal Trade Commission has requested additional information about MiMedx Group Inc.'s planned $350 million purchase of Sanara MedTech Inc., a company that develops and commercializes products for use during surgery.

  • October 16, 2026

    City Therapeutics' Upsized $200M IPO Joins Biotech Wave

    Blood clot-focused biotechnology firm City Therapeutics began trading publicly Friday after raising $200 million in its upsized initial public offering steered by Goodwin Procter LLP and Cooley LLP, joining a wave of biotechnology public listings over the past few weeks.

  • October 16, 2026

    Could A Criminal Sentencing Case Upend Loper Bright?

    U.S. Supreme Court Justice Neil Gorsuch is concerned that a ruling instructing trial courts to defer to the U.S. Sentencing Commission's interpretation of federal sentencing guidelines could blow a "pretty big hole" in the court's recent rejection of deference doctrines. His colleagues, however, don't appear as perturbed.

  • October 16, 2026

    States Win 1st OK Of $400M Sandoz Generic Price-Fixing Deal

    A Connecticut federal judge granted preliminary approval Friday to a $400 million settlement between a coalition of states, Sandoz Inc. and its subsidiary Fougera Pharmaceuticals Inc. over allegations of generic drug price-fixing and market allocation, setting aside $280 million as restitution.

  • October 16, 2026

    Aetna Drops Medical Billing Suit Against Acupuncture Clinic

    Aetna, a Washington acupuncture clinic and a retired doctor have agreed to end the insurer's suit claiming it paid more than $800,000 because of fraudulent billing for medical services, according to a federal court filing.

  • October 16, 2026

    Conn. Doctor Settles Fraud Claims Over COVID Test Billing

    A Connecticut doctor who has pursued numerous lawsuits against insurers for COVID-19 testing reimbursements, with a mixed record of success, has agreed to pay more than $850,000 to settle allegations that his companies submitted inflated bills to government programs, authorities said Friday.

  • October 16, 2026

    Former Connecticut Budget Boss' 2nd Bribery Trial Delayed

    A Connecticut federal judge Friday rescheduled a Medicaid audit-related corruption trial for former state budget official Konstantinos Diamantis, who remains on the lam after fleeing to Greece as sentencing neared in an earlier corruption case connected to school construction bribes.

  • October 16, 2026

    China Tightens Export Controls On AI, Biotech Technologies

    China will add 40 new products spanning across the artificial intelligence, biotechnologies and photovoltaic sectors to a pre-export registration requirements list, the Chinese Ministry of Commerce announced Friday.

  • October 16, 2026

    Brokers Sue CMS Over Moratorium On ACA Registration

    A trade group for brokers and other health insurance professionals urged a Maryland federal court to halt the U.S. Center for Medicare and Medicaid Services' moratorium on new registrations of agents and brokers, arguing the policy and a related rule don't comply with administrative procedure.

  • October 16, 2026

    'Defend To The End': Atty Admits Error In Gucci Glasses Suit

    An attorney blamed a "defend to the end" attitude he'd developed while fighting foreclosures for turning a client's dispute over $399 Gucci glasses into a multiyear legal morass that landed him in front of a Pennsylvania disciplinary panel on Friday.

  • October 16, 2026

    Taxation With Representation: Freshfields, Morgan Lewis

    In this week's Taxation With Representation, Penske Automotive Group Inc. agrees to be taken private by Motown Acquisition Corp., a GTCR-led group of private investment firms acquires software firm CCC Intelligent Solutions Holdings Inc. and a Steris PLC subsidiary buys specialty surgical products business Xodus Medical Inc.

  • October 16, 2026

    11th Circ. Backs Florida Firm In Lender Note Verdict Appeal

    The Eleventh Circuit in an unpublished opinion backed a law firm accused of botching several financial transactions for a Puerto Rican microcap lender, affirming the findings of a jury and a lower court that it didn't commit malpractice by failing to secure the company's assets during bankruptcy proceedings.

Expert Analysis

  • FDA Closeout Letter Suggests Relaxing Stance On Wearables

    Author Photo

    The U.S. Food and Drug Administration's recent decision not to pursue enforcement action against Whoop's wearable blood pressure tracker, read together with guidance released earlier this year, suggests a softer shift in the FDA's approach to regulating wearables, say attorneys at Arnold & Porter.

  • Justices' Hikma Reasoning May Extend Well Beyond Pharma

    Author Photo

    The active steps framework announced by the U.S. Supreme Court in its Hikma v. Amarin decision, finding that Amarin failed to plausibly allege inducement of infringement, has the potential to reshape how courts evaluate inducement claims across patent, copyright and other doctrines, say attorneys at BCLP.

  • Teva MDL Loss Shows DPAs Can Return To Haunt Civil Suits

    Author Photo

    Teva’s recent partial summary judgment loss in antitrust multidistrict litigation reinforces the importance of carefully scrutinizing any statement of facts a company admits to in a deferred prosecution agreement, and illustrates the potential costs of resolving a criminal investigation this way, say attorneys at Sheppard.

  • 11th Circ. FCA Qui Tam Revival Queues Up Next Challenges

    Author Photo

    Though the Eleventh Circuit on Sept. 1 upheld the constitutionality of the False Claims Act's qui tam provision, it will probably face continued litigation since the appellate court declined to rule on other constitutional challenges and the decision will likely be petitioned to the U.S. Supreme Court, say attorneys at Sheppard.

  • Prepping Health Businesses For Sale In A Data-Driven Market

    Author Photo

    In a thinner market for healthcare transactions, with both regulators and buyers using artificial intelligence to inspect data in great detail, the margin for error in sellers' financials and legal diligence has narrowed, requiring more proactive compliance efforts, says Cody Dumas at FBFK Law.

  • Series

    Ballet Makes Me A Better Lawyer

    Author Photo

    A lifetime of learning and performing ballet taught me that success — whether in dance or practicing law — comes only through hours of thorough preparation, boundless energy and relentless effort, says Sharon Katz-Pearlman at Greenberg Traurig.

  • Rejection Of NLRB Successor Bar Renews An Employer Tool

    Author Photo

    Although the D.C. Circuit's recent ruling in Hospital Menonita v. National Labor Relations Board does not allow purchasers to disregard incumbent unions, employers acquiring a unionized business have regained a tool to challenge a union's majority support, say attorneys at Bass Berry.

  • NY Ethics Opinion Warns Attys On Qui Tam Deception

    Author Photo

    A recent New York State Bar Association ethics opinion cautions that counsel representing whistleblowers may not induce, supervise or facilitate a client's deceptive prefiling investigations, creating a potential vulnerability for qui tam complaints built on questionable evidence-gathering methods, say attorneys at Sidley.

  • DOJ Fraud Declination Highlights Self-Disclosure Tradeoffs

    Author Photo

    As exemplified by the U.S. Department of Justice's declination of charges against Campus Eye Management under its new corporate enforcement policy, self-disclosure can be an attractive option for healthcare companies navigating criminal exposure, but should be weighed against potential costs, say attorneys at Morgan Lewis.

  • Insurer Spoliation Ruling Flags Continuing Duty To Preserve

    Author Photo

    An Illinois federal court’s recent decision to impose spoliation sanctions on the insurer in H.D. Smith v. Cincinnati Insurance provides practical guidance for navigating long-tail coverage litigation, underscoring the importance of evaluating preservation obligations in light of the full life cycle of a dispute, say attorneys at Morgan Lewis.

  • What DOJ Fraud Division Rule Resolves, And What It Doesn't

    Author Photo

    The U.S. Department of Justice’s recently published final rule answers many outstanding questions about the newly created National Fraud Enforcement Division, but overlapping mandates could result in parallel investigations and diverging viewpoints between multiple sets of prosecutors, say attorneys at Gibson Dunn.

  • Series

    Taekwondo Makes Me A Better Lawyer

    Author Photo

    Taekwondo has taught me to recognize when to fight for a position and when to focus on finding a solution, and that the best outcomes are often achieved by solving problems — all of which has improved my work as a bankruptcy lawyer, mediator and Subchapter V trustee, says Amy Denton Mayer at Berger Singerman.

  • Youth Center Investigation Shows Rising Governance Scrutiny

    Author Photo

    A recent New Hampshire attorney general report following its investigation into the state's Sununu Youth Services Center shows how organizations serving vulnerable populations can face scrutiny of their governance, safety practices and preparedness, even when investigators find no abuse, say attorneys at Morgan Lewis.

  • Target's ERISA Win Doesn't Ax Tobacco Surcharge Questions

    Author Photo

    Though a Minnesota federal court's recent dismissal of a putative class action challenging Target's tobacco surcharge wellness program offers employers a defense road map, courts' differing conclusions about the Employee Retirement Income Security Act versus U.S. Department of Labor requirements leave the legal landscape unsettled, say attorneys at McGuireWoods.

  • How 'Most Favored Nation' Regime Affects Biopharma Deals

    Author Photo

    As M&A activity surges in the biopharma space, companies will need to account for the Trump administration's most-favored-nation pricing proposals — durable in concept, if unsettled in detail — when drafting deals, say attorneys at Gibson Dunn.

Want to publish in Law360?


Submit an idea

Have a news tip?


Contact us here
Can't find the article you're looking for? Click here to search the Health archive.